SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001279569-06-001042
Filing Date
2006-09-25
Accepted
2006-09-22 19:17:59
Documents
12
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 40-F ym40f.htm 40-F 87974
2 AIF ex991.htm EX-99.1 680820
3 MD&A ex992.htm EX-99.2 136973
4 ANNUAL FINANCIAL STATEMENTS ex993.htm EX-99.3 1367505
5 CERTIFICATION OF CEO RULE 13A-14(A) OR 15D-14 ex994.htm EX-99.4 20748
6 CERTIFICATION OF CFO RULE 13A-14(A) OR 15D-14 ex995.htm EX-99.5 21606
7 SECTION 1350 CERTIFICATION CEO ex996.htm EX-99.6 6183
8 SECTION 1350 CERTIFICATION OF CFO ex997.htm EX-99.7 5944
9 CONSENT OF KPMG LLP ex998.htm EX-99.8 14794
10 KPMGLOGO kpmglogo.jpg GRAPHIC 9001
11 KPMGSIG kpmgsig.jpg GRAPHIC 2658
12 YM CHART ymchart.jpg GRAPHIC 30739
  Complete submission text file 0001279569-06-001042.txt   2402616
Mailing Address
Business Address 5045 ORBITOR DRIVE BUILDING 11 SUITE 400 MISSISSAUGA A6 00000
YM BIOSCIENCES INC (Filer) CIK: 0001178347 (see all company filings)

IRS No.: 000000000
Type: 40-F | Act: 34 | File No.: 001-32186 | Film No.: 061105363
SIC: 2834 Pharmaceutical Preparations